New research shows indigenous peoples are much more likely to be infected by hepatitis B and/or C

August 9, 2017, World Hepatitis Alliance
A microscopic image of the Hepatitis B virus, taken by the Centers for Disease Control and Prevention

A new meta-analysis of global hepatitis data—presented at this year's World Indigenous Peoples' Conference on Viral Hepatitis in Anchorage, Alaska, USA (8-9 August)—shows that Indigenous Peoples are up to 10 times more likely to be infected by viral hepatitis than the general population in their respective countries. The analysis is presented by Dr Homie Razavi and Devin Razavi-Shearer, The Polaris Observatory, Lafayette, CO, USA.

Both B and hepatitis C are viral infections, which, if left untreated, can cause serious liver damage, liver cancer, and ultimately death. Both can be transmitted through contact with the blood of an infected person, sexual transmission, injection drug use, unsafe medical procedures and tattooing where equipment has not been sterilised. Hepatitis B is also commonly sexually transmitted.. For hepatitis C, people who received a blood transfusion before 1992 when universal blood screening practices were introduced in most high-income countries, are also at risk.

An estimated 71 million people worldwide have chronic hepatitis C infection; for hepatitis B the numbers are higher at 257 million. Most people with hepatitis B virus are adults infected before the hepatitis B vaccine became widely available.

In this new research, the authors reviewed prevalence of both viruses in the Indigenous Peoples and general populations of North America, South America, Australia, and New Zealand. For hepatitis C, data that could be extrapolated to the general population was found for 11 countries and included 23 specific Indigenous Peoples and nations as well as 12 more broad groupings, covering the period from 1991 onwards.

The data showed that, compared to general populations in their countries:

  • Hepatitis C rates among Aboriginal and Torres Straight Islanders are 3 times higher
  • In Canada, the Inuit and Métis First Nations Canadians also have rates 3 times higher
  • In New Zealand, the data were insufficient to produce reliable estimates
  • In the continental USA, American Indian tribal citizens overall had rates 2.5 times higher
  • In Alaska, there was no statistically significant difference in the rate of hepatitis C in Alaskan natives.

The authors say: "The higher prevalence of anti-HCV observed in Indigenous Peoples and nations can be the result of disproportionately high rates of poverty, injection drug use, and incarceration in Iindigenous populationsPopulations. This, in combination with the lack of access to healthcare and prevention measures, greatly increases the risk and thus prevalence of hepatitis C."

For hepatitis B, prevalence was reviewed among Indigenous Peoples and nations of North America, South America, Australia, and New Zealand. Data that is suitable for extrapolation was found for 13 countries and included 106 specific Indigenous Peoples and nations as well as 22 more broad groupings.

The data showed that, compared with their respective general populations:

  • Aboriginal and Torres Straight Islanders in Australia were 4 times more likely to have hepatitis B infection
  • Maori and Pacific Islander populations in New Zealand had double the rates of hepatitis B
  • Canadian First Nations Inuit and Metis peoples had an even higher disparity, with hepatitis B rates five times higher

While USA Alaskan native populations had rates of hepatitis B 10 times that of general population (the largest disparity found), the studies included did not take into account universal hepatitis B vaccination in that state that has almost wiped out new infections in young people, and this will have brought down overall hepatitis B prevalence in recent years

The authors add that today, hepatitis B vaccination rates are similar among Indigenous and non-Indigenous young people across the USA.

The authors say: "The distribution of the prevalence of hepatitis B varies greatly among different indigenous Peoples and nations, and in some Indigenous Peoples of the Amazon it has been reported that the prevalence can even vary drastically by village. The disparities in access to healthcare, prevention, and treatment in particular have continued to reinforce the prevalence, morbidity and mortality disparities that are seen."

Raquel Peck, Chief Executive of the World Hepatitis Alliance, London, UK, said: "These data confirm that Indigenous Peoples worldwide are bearing a disproportionately high burden of hepatitis B, hepatitis C, or both. More must be done to ensure that Indigenous Peoples everywhere are at the heart of hepatitis treatment and prevention programs."

Explore further: Vaccination succeeds in dramatically reducing hepatitis B in NSW Aboriginal women

Related Stories

Vaccination succeeds in dramatically reducing hepatitis B in NSW Aboriginal women

April 19, 2017
There has been a significant reduction in hepatitis B virus in Aboriginal women giving birth in NSW, with the decline linked to the introduction of the state's newborn vaccination program.

Around 9 million Europeans are affected by chronic hepatitis B or C

July 26, 2017
An estimated 4.7 million Europeans are living with chronic hepatitis B and almost 4 million (3.9) with chronic hepatitis C infection. However, large numbers of them are not even aware of their infection as they have not yet ...

Cases of hepatitis B and C hit 325 million: WHO

April 21, 2017
An estimated 325 million people are living with hepatitis B or C and few are aware of their condition, with death tolls from the viruses rising, the UN said Friday.

Hepatitis C nearly triples in US in 5 years

May 11, 2017
The number of hepatitis C infections have nearly tripled in the United States in the last five years, particularly among people in their 20s, researchers said Thursday.

Latest research shows Australia on track to cure hepatitis C

February 21, 2017
More Australians have been treated for hepatitis C in the past 12 months than the last decade combined, following the listing of a new generation therapy on the Pharmaceutical Benefits Scheme.

Hepatitis B and C may be linked to increased risk of Parkinson's disease

March 29, 2017
The viruses hepatitis B and C may both be associated with an increased risk of Parkinson's disease, according to a study published in the March 29, 2017, online issue of Neurology, the medical journal of the American Academy ...

Recommended for you

New strategy to cure chronic hepatitis B infection

May 18, 2018
Scientists from Karolinska Institutet and Hannover Medical School have published two studies that provide insights into how the immune system responds and helps to clear a hepatitis B infection after treatment interruption. ...

Blood type affects severity of diarrhea caused by E. coli

May 17, 2018
A new study shows that a kind of E. coli most associated with "travelers' diarrhea" and children in underdeveloped areas of the world causes more severe disease in people with blood type A.

Resistance to antifungal drugs could lead to disease and global food shortages

May 17, 2018
Growing levels of resistance to antifungal treatments could lead to increased disease outbreaks and affect food security around the world.

Pig immunology comes of age: Killer T cell responses to influenza

May 17, 2018
Researchers from The Pirbright Institute, University of Bristol, Cardiff University and University of Oxford have generated tools that allow scientists to understand a vital area of the pig immune system which was previously ...

How intestinal worms hinder tuberculosis vaccination

May 17, 2018
New research in mice suggests that chronic infection with intestinal worms indirectly reduces the number of cells in lymph nodes near the skin, inhibiting the immune system's response to the Bacille Calmette-Guerin (BCG) ...

Mosquito spit may affect your immune system for days

May 17, 2018
Mosquito saliva alone—even in the absence of any pathogens—contains hundreds of proteins. Now, researchers reporting in PLOS Neglected Tropical Diseases have discovered that the interaction of these proteins with the ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.